The "Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.
This report provides comprehensive information about the Peripheral Nerve Stimulators (PNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A Peripheral nerve stimulation device is similar to the spinal cord stimulation (SCS ) device that is used to treat chronic pain disorders. A PNS is comprised of an electrical pacemaker that stimulates the peripheral nerve through the surgically-implanted electrodes.
Scope
Reasons to Buy
Key Topics Covered:
1 Tables & Figures
2 Introduction
2.1 Peripheral Nerve Stimulators (PNS) Overview
3 Products under Development
3.1 Pipeline Products by Stage of Development
3.2 Pipeline Products by Territory
3.3 Pipeline Products by Regulatory Path
3.4 Pipeline Products by Estimated Approval Date
3.5 Ongoing Clinical Trials
4 Peripheral Nerve Stimulators (PNS) - Pipeline Products under Development by Companies
4.1 Peripheral Nerve Stimulators (PNS) Companies - Pipeline Products by Stage of Development
4.2 Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development
5 Peripheral Nerve Stimulators (PNS) Companies and Product Overview
5.1 Actuated Medical Inc Company Overview
5.1.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Bioness Inc Company Overview
5.3 Cala Health Inc Company Overview
5.4 Cardionomic Inc Company Overview
5.5 Charco Neurotech Ltd Company Overview
5.6 Checkpoint Surgical Inc Company Overview
5.7 EMKinetics, Inc. Company Overview
5.8 Epineuron Technologies Inc Company Overview
5.9 Gondola Medical Technologies SA Company Overview
5.10 Noctrix Health Inc Company Overview
5.11 Remedee Labs SAS Company Overview
5.12 SPR Therapeutics LLC Company Overview
5.13 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.14 TheraNova LLC Company Overview
5.15 Washington University School of Medicine Company Overview
6 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/ialwbs